The induction of apoptosis during cytokine-induced proliferation of hematopoietic stem and progenitor cells (HSPC) may result in the loss of hematopoietic function. We tested the ability of several caspase inhibitors to maintain transplantation potential of mouse HSPC during in vitro culture. HSPC were isolated from mouse bone marrow by cell sorting and cultured in the presence of steel factor (STL) with or without various caspase inhibitors. After incubation, cells were harvested and tested for in vitro colony-forming cell (CFC) potential and transplantation activity in both short-and long-term in vivo assays. HSPC required STL to retain CFC activity during a 24-h culture at 37°C, and none of three caspase inhibitors could substitute for STL in this respect. In transplant assays, a twofold higher frequency of animals showed donor-derived blood cells 12 weeks after competitive transplantation of 50 HSPC cultured for 4 h in the presence of STL plus n-acetyl-Tyr-Val-Ala-Asp-chloromethyl ketone (ac-YVAD) compared with 50 cells cultured in STL alone.
INTRODUCTION
engraftment potential when expanded cells were transplanted. One possible explanation for reduced stem cell poten-Autologous and allogenic blood stem cell transplantation is an increasing therapeutic option for many dis-tial following ex vivo expansion could be the induction of programmed cell death (PCD) during in vitro culture eases, but stem cell harvest is still one limiting factor. An in vitro expansion of hematopoietic stem and pro-or shortly after transplantation of cultured cells. Traycoff et al. (17) demonstrated that the decline of HSPC genitor cells (HSPC) prior to transplantation could potentially overcome this problem. Stem cells are defined activity is coupled with an increase in apoptosis of ex vivo expanded CD34 + cells. In the past decade, mecha-by the capacity for self-renewal and the ability to differentiate into all blood cell lineages. Although HSPC cul-nisms of PCD have been under intense scientific investigation (18, 20, 23) . As a result, we now know that PCD tured in vitro with the support of various cytokine combinations expand with respect to cell numbers and is triggered by a variety of stimuli including glucocorticoids, ionizing irradiation, or growth factor withdrawal. colony-forming potential (15), transplantable stem cell activity is usually decreased or at best only maintained This leads to the activation of a cell death pathway that involves a family of proteases, the so-called caspases during culture (5, 7) . One reason for this may be that stem cells, which are largely cell cycle quiescent, lose (cysteine proteases with aspartate specificity), which are related to the Caenorhabditis elegans cell death gene some potential of self-renewal when progressing into cell cycle. We recently reported that exposing in vitro product CED-3 (24). A variety of peptide inhibitors of caspase function have recently been developed, and cultured HSPC to TGF-β increases the percentage of cells in G 0 /G 1 to the level of uncultured HSPC (21).
Schierle et al. reported a reduction of apoptosis and an increase in survival after transplantation of embryonic However, this manipulation did not result in increased 352 WIESMANN ET AL. nigral cells that had been cultured in the presence of a Caspase Inhibitors synthetic inhibitor of interleukin-1 beta-converting en-Caspase inhibitors tert-butoxycarbonyl-Asp-(O-methyl)zyme (ICE), a CED-3 homolog (8) . Recent data suggest fluoromethyl ketone (boc-D), n-acetyl Asp-Glu-Val-Aspa closer linkage between blood and brain stem cells than chloromethyl ketone (ac-DEVD), and n-acetyl Tyr-Valpreviously thought (1), and it is therefore not surprising Ala-Asp-chloromethyl ketone (ac-YVAD) were purchased that Sloand et al. were able to show an increased expanfrom Calbiochem (La Jolla, CA). Caspase inhibitors sion of the proliferative potential of human hematopoiwere dissolved in DMSO and added to short-term culetic progenitors cultured in the presence of the same tures at the indicated concentrations. Final concentrasynthetic inhibitor (10) . In this study we sought to examtions of DMSO did not exceed 2%. ine the in vitro and in vivo effect of caspase inhibitors Colony-Forming Unit Culture (CFU-C) Assay on the hematopoietic potential of in vitro cultured mouse HSPC.
Cells were plated at a concentration of 100 cells/ml in a methylcellulose mixture consisting of Corp., Seattle, WA). Cells were plated in 35-mm dishes, isolated by teasing with forceps. Both cell suspensions incubated at 37°C in 5% CO 2 /95% air, and colonies were subjected to repeated pipetting and filtered through were counted on day 9 or 10. a nylon mesh (85 µm; Small Parts Inc., Miami Lakes, FL) to remove debris and connective tissue.
Liquid Culture For liquid culture, the desired number of cells were Enrichment of Hematopoietic Stem sorted into 96-well microtiter plates containing 50 µl and Progenitor Cells MEM-α (Gibco BRL) supplemented with 10% fetal calf Bone marrow cells were magnetically lineage deserum. STL (50 ng/ml) and caspase inhibitors were pleted and stained with phycoerythrin-conjugated antiadded as indicated. Cells were incubated for the indi-Sca-1 (PharMingen, Inc., San Diego, CA) as previously cated time (usually 4 h) at 37°C in 5% CO 2 /95% air. described (11) . A FACS-Vantage instrument (Becton After in vitro culture, cells were recovered from the Dickinson Immunocytometry Systems, San Jose, CA) plates and placed into methylcellulose cultures or transwas used for a Sca-1 enrichment sort from the lineageplanted into lethally irradiated mice. In competitive redepleted bone marrow population by triggering on PE population assays, fresh bone marrow cells were added emissions and sorting for cells expressing PE fluoresto cultured cells immediately prior to transplant. cence above background levels using the sorter enrich Irradiation, Transplantation, and Reconstitution mode. Sorted cells were further stained with Oregongreen-conjugated anti-Thy-1.1 (19XE5), allophycocy-Recipient B6 animals were exposed to 13 Gy of irradiation from a 137 Cs source (Mark I gamma irradiator; anin-conjugated anti-c-kit (CD117; PharMingen, Inc., San Diego, CA), and propidium iodide as a viability Shepherd and Associates, Glendale, CA) at a dose rate of 0.5 Gy/min. The dose was delivered in two equal marker. Cells were sorted for the Thy low Sca-1 pos c-kit pos population, collected by centrifugation, and a small sam-fractions separated by approximately 3 h. For competitive repopulation experiments, sorted cells (Thy-1.1/Ly-ple was removed for reanalysis to confirm purity and yield.
5.1) were mixed with bone marrow cells isolated from normal B6 mice (Thy-1.2/Ly-5.2), and the cell suspension in vitro preculture, the CFU-C potential was rescued to a level comparable to that observed without preculture. was collected in 0.5-cc syringes. Cells were injected retroorbitally into irradiated B6 mice under methoxyflurane To evaluate dosage effects of caspase inhibitors on CFU-C activity in this culture system, boc-D, ac-DEVD, anesthesia (Metofane  , Mallinckrodt Veterinary, Inc., Mundelein, IL) such that each animal received 1 × 10 5 or ac-YVAD was added to the 24-h preculture at concentrations ranging from 50 to 250 µM. Our initial ex-normal bone marrow cells and 50 sorted cells. Irradiated and transplanted mice were maintained in a pathogen-periments sought to establish dose ranges of these caspase inhibitors that would not be toxic to hematopoietic free environment and neomycin sulfate (Biosol  , Upjohn Company, Kalamazoo, MI) was added to the drinking progenitors, as assessed by inhibition of hematopoietic colony formation. In addition, we evaluated the ability water at a concentration of 2 mg/ml for the following 2 weeks.
of caspase inhibitors to substitute for the viability-promoting activity of STL during the 24-h preculture. Our ex-
Analysis of Transplant Recipients
periments showed that none of the tested caspase inhibi-At various times after transplantation, peripheral blood tors were able to rescue the CFU-C potential of sorted samples were collected by retro-orbital bleeding. Platelet HSPC cultured in the absence of STL (data not shown). counts and hematocrit values were determined using a Figure 1B shows the effect of including caspase in-System 9010 + CP hematology analyzer (Serono-Baker hibitors along with STL during the preculture prior to Diagnostics, Allentown, PA). Due to occasional difficulthe CFU-C assay. None of the tested caspase inhibities distinguishing between white blood cells (WBC) and tors could significantly increase the CFU-C potential of clumps of activated platelets using the Serono counter, Thy low cells above the level that was achieved by culture WBC counts were determined by nuclear counting using with STL alone. Caspase inhibitors at concentrations of an automated cell counter (Model Z F , Coulter Electron-25 and 50 µM caused no changes in colony-forming poics, Hialeah, FL). Mononuclear cells were isolated as tential, but at higher concentrations of boc-D and acpreviously described (11) and immunfluorescently stained YVAD a decrease in colony formation was observed to identify congenic cells based on expression of Ly-5.1 (Fig. 1B) . Therefore, for subsequent experiments all cas- (9) . Lymphoid and myeloid lineages were detected using pase inhibitors were used at a concentration of 50 µM. specific monoclonal antibodies as previously described
Because previous studies have shown that engraftment (13). These stains utilized PE-conjugated lymphoid and potential decreases rapidly with in vitro culture (21), we myeloid antibodies with fluorescein-conjugated anti-Lylimited the time in culture for transplant experiments to 5.1 (A20; PharMingen, Inc., San Diego, CA). Lymphoid 4 h in the presence of STL plus the various caspase inand myeloid lineages were detected using phycoeryhibitors. We reasoned that 4 h would allow sufficient thrin-conjugated antibodies specific for T cells (CD4 time for inhibition of caspase-mediated effects that may and CD8), B cells (B220), or myeloid cells (Mac1 and occur during the engraftment process. Gr-1). Antibodies against CD4 (YTS 191.1), CD8 (53-Influence of Caspase Inhibitor Preculture 6.7), B220 (RA3-6B2), Mac-1 (M1/70), and Gr-1 (RB6on Long-Term Engraftment Potential of HSPC 8C5) were purified from media of cultured hybridoma cell lines and conjugated with phycoerythrin in our labo-
The most comprehensive test of stem cell potential ratory or purchased from PharMingen.
utilizes the competitive long-term repopulation assay. By using animals with different allelic epitopes of the RESULTS Ly-5 antigen, donor-and host-derived WBC can be dis-Influence of Caspase Inhibitors on Colony-Forming tinguished in recipient animals (12). Thy low cells (Ly-Unit Culture (CFU-C) Activity 5.1) were isolated and cultured for 4 h in the presence of STL with or without different caspase inhibitors. To test the influence of caspase inhibitors on the functional potential of mouse hematopoietic cells, Thy-After this preculture, cells were harvested and 50 Thy low cells were transplanted per mouse along with 10 5 normal 1.1 low Sca-1 pos c-kit pos (Thy low ) cells were isolated from bone marrow by cell sorting. Sorted cells were plated in bone marrow cells (Ly-5.2) as a source of radioprotection. Recipient animals were analyzed at different time methylcellulose containing recombinant cytokines either immediately upon isolation or after a 24-h culture in the points after transplantation for donor-derived WBC. As shown in Figure 2 , only one of eight animals trans-presence or absence of steel factor (STL). As shown in Figure 1A , Thy low cells cultured in methylcellulose im-planted with cells cultured in the presence of STL alone showed significant donor-derived WBC in the peripheral mediately after isolation resulted in about 30 colonies per 100 cells plated. In contrast, an in vitro preculture blood 12 weeks after transplantation. Engraftment potential was potentiated if either ac-YVAD or boc-D was of 24 h in media with no cytokine support reduced the CFU-C activity to almost zero. If STL was added to the included in the preculture. In either case, three out of eight transplanted animals showed Ly-5.1-positive hematopoietic engraftment as a donor contribution that included T cells, B cells, and myeloid cells and consti-WBC. In contrast, ac-DEVD had no effect on engraftment potential. This was unlikely to be due to a nonspe-tuted greater than 10% of the total peripheral WBC. A control group of five mice transplanted with 50 Thy low cific inhibitory effect of this compound, as no effect on CFU-C activity was observed at this dose (Fig. 1B) , and cells that were held on ice during the 4 h of culture resulted in two engrafted mice ( Fig. 3) . Transplantation the combination of all three caspase inhibitors was similar to ac-YVAD in terms of engraftment potential ( Fig. of 50 Thy low cells cultured in STL alone resulted in engraftment of an equal frequency of mice (4 of 10). Cells 2). These results are consistent with previous reports that ac-YVAD can inhibit Fas-mediated apoptosis (3), and cultured in STL plus ac-YVAD promoted robust engraftment in 8 of 10 mice, a twofold increase over the that boc-D is a broad-spectrum caspase inhibitor (2) . The failure of ac-DEVD to enhance engraftment in these other two experimental groups. This experiment confirms the results shown in Figure 2 and suggests that the assays is difficult to reconcile, because the target of this inhibitor, caspase-3, is at the effector end of the caspase activity of ac-YVAD in this experimental system is to augment engraftment of long-term repopulating cells cascade (16). The failure to observe protection of engraftment may be due to suboptimal solubility, perme-compared with freshly isolated cells or cells cultured in STL alone. To summarize these experiments, preincu-ability, or activity of this compound, or may indicate a PCD effector pathway that does not involve caspase-3. bation of Thy low HSPC in cultures containing STL plus ac-YVAD and, to a lesser extent, boc-D resulted in aug-Subsequent experiments were performed using only the ac-YVAD compound.
mented long-term engraftment after intravenous transplantation. To confirm the ability of ac-YVAD to maintain longterm engraftment potential during a 4-h in vitro culture, Influence of ac-YVAD on Short-Term Engraftment we repeated the experiment in a second cohort of ani-
Kinetics of Thy low HSPC mals and compared cells incubated in STL with or without ac-YVAD. Previous studies have established that
To evaluate whether ac-YVAD also augments shortterm engraftment kinetics of transplanted cells, Thy low evaluation of transplant recipients 10-12 weeks after limiting dilution transplantation provides a close approx-cells were isolated, cultured as described above, and transplanted into lethally irradiated mice without the imation of long-term engraftment activity (11, 14) . Figure 3 shows peripheral blood analysis of recipient ani-support of supplemental bone marrow cells. Recipients were bled at different times posttransplant and blood mals 12 weeks after transplantation. We defined complete YVAD, resulted in a striking inhibition of erythroid engraftment during the first 2 weeks posttransplant ( Fig.  4 ). Transplant recipients of both cultured cell populations exhibited a significant depression in hematocrit values relative to uncultured controls on days 7, 10, and 14 posttransplant, and the nadir of hematocrit values was deeper (p < 0.01). A recovery in hematocrit values was observed in recipients of cells cultured under either condition at day 17, but this recovery was maintained only in recipients of cells cultured in the caspase inhibitor. At 22 days posttransplant, hematocrit values in recipients of cells cultured in STL alone were significantly lower than the other two groups (p < 0.02). By 36 days, the uncultured cells continued to recover at a faster rate than the cultured populations, although hematocrit values were still outside the normal range in all groups.
As a final parameter for evaluation of hematopoietic engraftment, we noted survival of animals at the end of the short-term engraftment experiment. We observed that a higher proportion of animals transplanted with cells cultured in the presence of ac-YVAD remained alive 37 days posttransplant compared with animals transplanted with cells cultured in STL alone. Animals transplanted with uncultured cells had the highest rate of survival (17 of 18, or 94%) followed by recipients of pared with STL alone, p = 0.06). The selective effect of animal death in the STL alone group might be expected to lead to an overestimate of the hematopoietic recovery samples were analyzed for cellular recovery in the monocyte, erythrocyte, and platelet lineages. Uncultured in these animals, because the surviving animals tend to have higher levels of engraftment. cells served as a control group. Three groups of mice were transplanted with each of the three cell popula-DISCUSSION tions, and animals in each of these groups were bled sequentially to assure that animals were not bled more One problem encountered during ex vivo expansion of HSPC is the loss of stem cell activity during in vitro frequently than once per week. The results of this experiment are illustrated in Figure 4 . Platelet recovery was proliferation. A likely mechanism for this reduction in stem cell potential is activation of apoptotic pathways similar among the groups until day 29, when recipients of uncultured cells and of cells cultured in STL plus ac-coincident with the proliferative response. Traycoff et al. (17) demonstrated for human CD34 + cells a positive YVAD exhibited a recovery in platelet counts. Recipients of cells cultured in STL alone remained at a level correlation between number of cell divisions in vitro and the onset of apoptosis. The family of caspase molecules that was significantly different from the other two groups (p < 0.05) until 1 week later, when all groups plays a key role in this signaling pathway and various caspase inhibitors can modulate the PCD process. showed evidence of recovery. Thus, platelet recovery was accelerated when preculture was performed in the In this study we examined the effect of several caspase inhibitors on maintenance of mouse HSPC activity presence of ac-YVAD.
The 4-h preculture in STL, with or without ac-during in vitro culture. We evaluated effects of the cul- ture on colony formation and on short-term and long-pase inhibitors did not show any advantage compared with the single use of ac-YVAD. A second experiment term repopulation of irradiated recipients of transplanted cells. The results indicate effects of caspase inhibition confirmed that preincubation of mouse HSPC in shortterm cultures containing ac-YVAD and STL resulted in on HSPC functions. Analysis of the frequency of apoptotic cells prior to and after the 4-h cultures was per-better engraftment than that observed following culture in STL alone (Fig. 3 ). In this case, cells cultured in the formed using the combination of Annexin-V and propidium iodide staining to discriminate apoptotic and necrotic presence of STL plus ac-YVAD generated a twofold higher frequency of engrafted animals compared with cells (19) . As might be predicted, we observed no change in the frequency of apoptotic cells during the 4-h uncultured cells or cells cultured in STL alone. The experiment shown in Figure 3 suggests that ac-YVAD pre-culture, and no effect of caspase inhibitors on viability or apoptosis in the short-term culture (data not shown).
serves or augments the engraftment potential of primitive HSPC cells during in vitro culture and the subsequent It is likely that the 4-h culture period is not sufficient to allow progression from the initiation to the execution homing process after transplantation. Whether this effect is due to inhibition of PDC or rather to other effects of phase of PCD. The period of time after transplantation that is required to allow homing of HSPC to the bone ac-YVAD remains to be determined. The observation that caspase inhibitors could increase marrow microenvironment is not well defined. We propose that the effect of caspase inhibition in this experi-the frequency of engrafting animals in a long-term reconstitution assay prompted us to test whether effects on mental setting is to provide protection from the initiation of PCD during the in vitro culture as well as during the short-term hematopoietic recovery could also be observed.
We were able to demonstrate an advantage in hemato-subsequent in vivo homing process.
None of the tested caspase inhibitors were able to poietic engraftment if cells were precultured with STL plus ac-YVAD compared with cultures containing STL rescue the dramatic decline in CFU-C potential seen after a 24-h in vitro culture in the absence of exogenous alone. Short-term culture in STL alone led to a delay in erythroid and platelet recovery (Fig. 4) . Animals trans-cytokines (Fig. 1A) . This result underscores the importance of survival-promoting cytokines such as STL in planted with HSPC cultured in STL plus ac-YVAD showed significantly faster engraftment in the erythroid maintaining the viability of isolated HSPC in vitro (6) . In the presence of STL, the colony formation after a 24-and platelet lineages compared with animals that received HSPC that were cultured in STL alone. Surpris-hour preculture was comparable to uncultured HSPC and could not be further increased by the addition of ingly, a 4-h culture in STL resulted in a significant depression of hematocrit values posttransplant, regardless caspase inhibitors (Fig. 1B) . After establishing the levels at which the caspase inhibitors could be included in 24-h of the presence of ac-YVAD in the cultures. This result underscores the deleterious effect of even short-term cultures without markedly inhibiting CFU-C potential, we changed our experimental design to a relatively short cultures on HSPC function in transplant settings. One mechanism for this effect may involve downregulation 4-h culture period in the presence of STL. This culture system was expected to reveal effects of caspase inhibi-of the receptor for STL due to the relatively high levels of the cytokine in the culture compared with levels in tion on the events that occur during the engraftment process. If PCD is initiated prior to the time of homing to vivo (4) . Because defects in STL or its receptor c-kit lead to diminished erythroid differentiation (22) , the a supportive niche in the hematopoietic microenvironment, inhibition of the apoptotic process might be ex-profound effect of the 4-h culture in the presence of STL on hematocrit may be related to decreased signaling pected to augment engraftment. The experiments were also designed to reduce the possibility of cell differentia-through c-kit as a result of ligand-induced receptor downregulation in culture. The effect of ac-YVAD on ery-tion during the short-term culture, because stem cell functions such as self-renewal and multilineage engraftment throid recovery was most pronounced between 20 and 30 days posttransplant, suggesting an effect on a more are decreased as a result of differentiation in culture.
In a first competitive long-term repopulation assay, primitive cell population. These experiments suggest that caspase inhibitors may be good candidates to facili-50 Thy low HSPC were transplanted together with 10 5 normal bone marrow cells as a source of radioprotection. Of tate maintenance of stem cell function during culture. Future experiments are required to characterize and opti-eight recipient animals, only one showed a significant percentage of donor-derived WBC after transplantation mize culture conditions under which the beneficial effects of caspase inhibitors are most striking, and to de-of cells cultured in the presence of STL alone. Addition of ac-YVAD or boc-D to the cultures resulted in an in-fine whether the mechanism of enhancement involves inhibition of PCD or whether other effects of the caspase crease in the number of engrafted animals. Transplantation of cells cultured in STL plus ac-DEVD resulted in inhibitor compounds are responsible for enhancing engraftment. one engrafted animal, and a combination of all three cas-
